期刊文献+

Treatment of Inflammatory Bowel Disease with Chinese Drugs Administered by Both Oral Intake and Retention Enema

Treatment of Inflammatory Bowel Disease with Chinese Drugs Administered by Both Oral Intake and Retention Enema
原文传递
导出
摘要 Objective:To study the clinical effect of Chinese drugs administered by both oral intake and retention enema on inflammatory bowel diseases(IBD).Methods:Adopting a randomized controlled design,78 patients were assigned to three groups:26 patients in group A treated with Chinese drugs given by both oral intake and retention enema,27 in group B with Chinese drugs given by retention enema only,and 25 in group C with given Western medicine.The changes before and after a 30-day treatment of the patients' symptoms (including diarrhea,abdominal pain,mucous or pus-bloody stool),colonoscopic examination scores and histopathology of the colonic membrane were observed.Results:Group A showed the best outcomes in all the aspects of clinical comprehensive effectiveness.Improvements in the main symptoms,colonoscopic scores and histopathology of the colonic membrane were significantly different from those in groups B and C,respectively (P〈0.05).Meanwhile comparisons between groups B and C showed insignificant differences(P〉0.05); group B was better in ameliorating tenesmus(P〈0.05).Conclusion:Through the use of Chinese drugs administered by both oral intake and retention enema to treat IBD,which combined external-internal therapies for both overall regulation and local managment,it was confirmed that the Chinese medicine could embody the therapeutic principle of attending to both disease-diagnosis and syndrome-differentiation. Objective:To study the clinical effect of Chinese drugs administered by both oral intake and retention enema on inflammatory bowel diseases(IBD).Methods:Adopting a randomized controlled design,78 patients were assigned to three groups:26 patients in group A treated with Chinese drugs given by both oral intake and retention enema,27 in group B with Chinese drugs given by retention enema only,and 25 in group C with given Western medicine.The changes before and after a 30-day treatment of the patients' symptoms (including diarrhea,abdominal pain,mucous or pus-bloody stool),colonoscopic examination scores and histopathology of the colonic membrane were observed.Results:Group A showed the best outcomes in all the aspects of clinical comprehensive effectiveness.Improvements in the main symptoms,colonoscopic scores and histopathology of the colonic membrane were significantly different from those in groups B and C,respectively (P〈0.05).Meanwhile comparisons between groups B and C showed insignificant differences(P〉0.05); group B was better in ameliorating tenesmus(P〈0.05).Conclusion:Through the use of Chinese drugs administered by both oral intake and retention enema to treat IBD,which combined external-internal therapies for both overall regulation and local managment,it was confirmed that the Chinese medicine could embody the therapeutic principle of attending to both disease-diagnosis and syndrome-differentiation.
出处 《Chinese Journal of Integrative Medicine》 SCIE CAS 2010年第3期222-228,共7页 中国结合医学杂志(英文版)
基金 Supported by Heilongjiang Administration of Traditional Chinese Medicine
关键词 inflammatory bowel disease outer-inner combined therapy retention enema clinical study inflammatory bowel disease outer-inner combined therapy retention enema clinical study
  • 相关文献

参考文献3

二级参考文献127

  • 1Riina Salupere Docent of Gastroenterology,Department of Internal Medicine University of Tartu,Estonia.Inflammatory bowel disease in Estonia:a prospective epidemiologic study 1993-1998a[J].World Journal of Gastroenterology,2001,7(3):387-388. 被引量:13
  • 2Spiros D.Ladas,Elias Mallas,Konstantinos Giorgiotis,Georgios Karamanolis,Dimitrios Trigonis,Apostolos Markadas,Vana Sipsa,Sotirios A.Raptis.Incidence of ulcerative colitis in Central Greece: A prospective study[J].World Journal of Gastroenterology,2005,11(12):1785-1787. 被引量:1
  • 3Annika Lapidus.Crohn's disease in Stockholm County during 1990-2001:An epidemiological update[J].World Journal of Gastroenterology,2006,12(1):75-81. 被引量:10
  • 4[1]Crohn BB,Rosenberg H.The sigmoidoscopic picture of chronic ulcerative colitis.Am J Med Sci 1925; 170:220-228
  • 5[2]Eaden JA,Abrams KR,Mayberry JF.The risk of colorectal cancer in ulcerative colitis:a meta-analysis.Gut 2001; 48:526-535
  • 6[3]Sachar DB.Cancer in Crohn's disease:dispelling the myths.Gut 1994; 35:1507-1508
  • 7[4]Bernstein CN,Blanchard JF,Kliewer E,Wajda A.Cancer risk in patients with inflammatory bowel disease:a population-based study.Cancer 2001; 91:854-862
  • 8[5]Kinzler KW,Vogelstein B.Lessons from hereditary colorectal cancer.Cell 1996; 87:159-170
  • 9[6]Fearnhead NS,Britton MP,Bodmer WF.The ABC of APC.Hum Mol Genet 2001; 10:721-733
  • 10[7]Morin PJ,Sparks AB,Korinek V,Barker N,Clevers H,Vogelstein B,Kinzler KW.Activation of beta-catenin-Tcf signaling in colon cancer by mutations in beta-catenin or APC.Science 1997; 275:1787-1790

共引文献79

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部